Does TOFACITINIB Cause Post procedural haemorrhage? 17 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Post procedural haemorrhage have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
17
Reports of Post procedural haemorrhage with TOFACITINIB
0.0%
of all TOFACITINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Post procedural haemorrhage From TOFACITINIB?
Of the 17 reports, 10 (58.8%) required hospitalization.
Is Post procedural haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Post procedural haemorrhage?
LEVONORGESTREL (1,106)
RIVAROXABAN (930)
ASPIRIN (618)
APIXABAN (539)
ADALIMUMAB (476)
IBRUTINIB (269)
CLOPIDOGREL BISULFATE (235)
HEPARIN (174)
WARFARIN (170)
DABIGATRAN ETEXILATE (121)
Which TOFACITINIB Alternatives Have Lower Post procedural haemorrhage Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN